Sign up
Pharma Capital

The Hydroponics Company showcases strategic plan at Proactive's CEO Sessions

Dr Andrew Beehag, chief executive officer for Canndeo, speaks with investors at the Proactive's Spotlight CEO Sessions.


View full THC profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.